{"id":"hepronicate","rwe":[],"tags":[{"label":"hepronicate","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"megrin","offLabel":[],"synonyms":["hepronicate","megrin"],"timeline":[],"approvals":[],"brandName":"Megrin","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"hepronicate","explanation":"Imagine your body's cells have locks on them, and Megrin has a key that fits into those locks. When Megrin binds to its target, it helps to regulate the activity of the cells, which can help to treat a particular condition. This is a simplified explanation of how Megrin works at a molecular level.","oneSentence":"Megrin works by interacting with a specific molecular target to produce a therapeutic effect.","technicalDetail":"Megrin is a hepronicate that binds to its target through a specific molecular interaction, potentially modulating its activity and leading to a therapeutic effect."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1359","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=HEPRONICATE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T13:51:20.102505","biosimilars":[],"competitors":[],"genericName":"hepronicate","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"E4RK86FAVR","CHEBI":"CHEBI:31668","INN_ID":"2733","UMLSCUI":"C1881038","ChEMBL_ID":"CHEMBL2106360","KEGG_DRUG":"D01882","PUBCHEM_CID":"3588"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Megrin (HEPRONICATE) is a small molecule drug in the hepronicate class, but specific details about its development, approval status, and commercial status are not available. As a hepronicate, it is likely used to treat a specific condition, but the exact target and indications are unknown. The safety profile and pharmacokinetic properties of Megrin are also not well-documented. Further research is needed to understand its clinical use and potential risks. As a result, Megrin is not a well-characterized drug.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}